Skip to main content
Premium Trial:

Request an Annual Quote

Putting Down the Odds

Steve Murphy at Gene Sherpas predicts that Complete Genomic will win the Archon X Prize for Genomics this year, but in the comments, Keith Robison is doubtful. "Complete Genomics is impressive, but the X-prize criteria are pretty onerous — I doubt they or PacBio will be gunning for it for at least 2 years," Robison writes. Daniel MacArthur also takes up the idea at his blog where he notes that those criteria include 98 percent coverage of each of the test genomes and no more than one error per 100,000 bases sequenced. Furthermore, MacArthur points out, to qualify for the prize this year, teams have to be registered by January 15th.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.